Targeting B-cell germlines and focusing affinity maturation: the next hurdles in HIV-1-vaccine development? | Expert Rev Vaccines;13(4): 449-52, 2014 Apr. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Search Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search

Targeting B-cell germlines and focusing affinity maturation: the next hurdles in HIV-1-vaccine development?

Medina-Ramírez, Max; Sanders, Rogier W; Klasse, Per Johan.

Expert Rev Vaccines ; 13(4): 449-52, 2014 Apr.

Article in En | MEDLINE | ID: mdl-24606603

Subject(s)

AIDS Vaccines/immunology; AIDS Vaccines/isolation & purification; Antibodies, Neutralizing/immunology; B-Lymphocytes/immunology; HIV Antibodies/immunology; HIV Infections/prevention & control; HIV-1/immunology; HIV Infections/therapy; Humans

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: B-Lymphocytes / HIV Antibodies / HIV Infections / HIV-1 / AIDS Vaccines / Antibodies, Neutralizing Limits: Humans Language: En Journal: Expert Rev Vaccines Journal subject: ALERGIA E IMUNOLOGIA Year: 2014 Type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: B-Lymphocytes / HIV Antibodies / HIV Infections / HIV-1 / AIDS Vaccines / Antibodies, Neutralizing Limits: Humans Language: En Journal: Expert Rev Vaccines Journal subject: ALERGIA E IMUNOLOGIA Year: 2014 Type: Article